Abstract
A series of 3,4-dihydro-3-hydroxy-4-[(5-oxo-3,4-diazabicyclo[4.1.0]hept- 2-en-2-yl)oxy]-2H-1-benzopyrans and their analogues were synthesized and evaluated on potassium channel opening and hypotensive activities. Compound (-)-13B with a (4-methyl-5-oxo-3,4-diazabicyclo[4.1.0]hept-2-en-2-yl)oxy group for the 4-position of the benzopyran ring was 3 times as potent as EMD 57283 (II), the lead compound, in hypotensive activity. The results would demonstrate that 5-oxo-3,4-diazabicyclo[4.1.0]hept-2-en-2-yloxy moieties are effective as the substituents at the 4-position of benzopyran-type potassium channel openers.
MeSH terms
-
Animals
-
Antihypertensive Agents / chemical synthesis*
-
Antihypertensive Agents / pharmacology
-
Benzopyrans / chemical synthesis*
-
Benzopyrans / pharmacology
-
Blood Pressure / drug effects
-
Bridged Bicyclo Compounds / chemical synthesis*
-
Bridged Bicyclo Compounds / pharmacology
-
Chromatography, High Pressure Liquid
-
Cromakalim / pharmacology
-
Crystallography, X-Ray
-
Heart Rate / drug effects
-
In Vitro Techniques
-
Male
-
Potassium Channels / drug effects*
-
Pyridazines / chemical synthesis*
-
Pyridazines / pharmacology
-
Rats
-
Rats, Inbred SHR
-
Rats, Wistar
-
Stereoisomerism
-
Structure-Activity Relationship
Substances
-
Antihypertensive Agents
-
Benzopyrans
-
Bridged Bicyclo Compounds
-
EMD 57283
-
Potassium Channels
-
Pyridazines
-
Cromakalim